Lupin on Wednesday said it has received approval from the USFDA for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease.
The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty’s Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement.
As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.
Shares of Lupin ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Humana members can visit humana.nationsbenefits.com to activate their spending account card online, check allowance balances,…
Concora Credit cardholders can quickly activate their credit card at concoracredit.com, through the mobile app,…
Facing a 504 Gateway Timeout error on your website? Learn what causes this problem and…
Discord showing “Stuck on Starting” is usually a small local error, not a global outage.…
Star Citizen Error Code 19005 is an account login timeout issue where the RSI Launcher…
Flash_status_error_universal on the OPPO and OnePlus Flash Tool usually happens due to wrong firmware, outdated…